NewLink Genetics EBITDA 2009-2019 | NLNK

NewLink Genetics ebitda from 2009 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
NewLink Genetics Annual EBITDA
(Millions of US $)
2018 $-61
2017 $-71
2016 $-89
2015 $-32
2014 $119
2013 $-30
2012 $-22
2011 $-17
2010 $-16
2009 $-10
2008 $-9
2007 $-8
NewLink Genetics Quarterly EBITDA
(Millions of US $)
Q2 2019 $-11
Q1 2019 $-10
Q4 2018 $-11
Q3 2018 $-15
Q2 2018 $-17
Q1 2018 $-18
Q4 2017 $-14
Q3 2017 $-21
Q2 2017 $-16
Q1 2017 $-21
Q4 2016 $-13
Q3 2016 $-17
Q2 2016 $-34
Q1 2016 $-25
Q4 2015 $-14
Q3 2015 $-15
Q2 2015 $-16
Q1 2015 $13
Q4 2014 $149
Q3 2014 $-13
Q2 2014 $-9
Q1 2014 $-9
Q4 2013 $-8
Q3 2013 $-8
Q2 2013 $-7
Q1 2013 $-8
Q4 2012 $-6
Q3 2012 $-6
Q2 2012 $-6
Q1 2012 $-5
Q4 2011 $-6
Q3 2011 $-4
Q2 2011 $-4
Q1 2011 $-4
Q4 2010
Q3 2010 $-5
Q4 2009
Q4 2008
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.068B $0.012B
NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink Genetics Corporation is headquartered in Ames, Iowa.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $118.105B 13.45
Gilead Sciences (GILD) United States $84.118B 10.33
CSL (CSLLY) Australia $72.183B 0.00
Celgene (CELG) United States $70.428B 10.90
Vertex Pharmaceuticals (VRTX) United States $45.783B 49.48
Illumina (ILMN) United States $45.507B 53.47
Biogen (BIIB) United States $44.044B 7.82
Regeneron Pharmaceuticals (REGN) United States $32.496B 14.75
Alexion Pharmaceuticals (ALXN) United States $23.840B 12.57
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $17.466B 51.40
Exact Sciences (EXAS) United States $13.463B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.451B 0.00
Genmab (GNMSF) Denmark $12.585B 70.59
Seattle Genetics (SGEN) United States $11.969B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.212B 54.74
Alnylam Pharmaceuticals (ALNY) United States $9.619B 0.00
Galapagos (GLPG) Belgium $8.830B 0.00
Bio-Techne Corp (TECH) United States $7.595B 52.47
QIAGEN (QGEN) Netherlands $7.593B 24.94
Guardant Health (GH) United States $6.873B 0.00
BeiGene (BGNE) Cayman Islands $6.435B 0.00
Sarepta Therapeutics (SRPT) United States $6.134B 0.00
Amarin (AMRN) Ireland $6.015B 0.00
Moderna (MRNA) United States $5.966B 0.00
Exelixis (EXEL) United States $5.925B 15.40
Bluebird Bio (BLUE) United States $5.903B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.886B 0.00
Horizon Pharma Public (HZNP) Ireland $5.084B 12.92
ARGENX SE-ADR (ARGX) Netherlands $4.778B 0.00
Ascendis Pharma (ASND) Denmark $4.613B 0.00
China Biologic Products (CBPO) China $4.495B 28.06
Repligen (RGEN) United States $4.215B 81.79
Blueprint Medicines (BPMC) United States $3.973B 0.00
Spark Therapeutics (ONCE) United States $3.939B 0.00
Medicines (MDCO) United States $3.897B 0.00
MorphoSys AG (MOR) Germany $3.695B 0.00
Mirati Therapeutics (MRTX) United States $3.672B 0.00
Alkermes (ALKS) Ireland $3.331B 0.00
Immunomedics (IMMU) United States $3.185B 0.00
Reata Pharmaceuticals (RETA) United States $2.842B 0.00
MyoKardia (MYOK) United States $2.828B 0.00
Genomic Health (GHDX) United States $2.646B 49.63
CRISPR Therapeutics AG (CRSP) Switzerland $2.642B 0.00
Emergent Biosolutions (EBS) United States $2.635B 39.58
Arena Pharmaceuticals (ARNA) United States $2.545B 5.47
Ultragenyx Pharmaceutical (RARE) United States $2.456B 0.00
Amicus Therapeutics (FOLD) United States $2.406B 0.00
Halozyme Therapeutics (HALO) United States $2.395B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.285B 0.00
Acceleron Pharma (XLRN) United States $2.271B 0.00
NeoGenomics (NEO) United States $2.268B 121.33
Akcea Therapeutics (AKCA) United States $2.090B 0.00
Zai Lab (ZLAB) China $2.023B 0.00
Myriad Genetics (MYGN) United States $2.017B 21.16
Cambrex (CBM) United States $2.008B 25.39
Ligand Pharmaceuticals (LGND) United States $1.977B 25.00
UniQure (QURE) Netherlands $1.760B 0.00
Insmed (INSM) United States $1.747B 0.00
Denali Therapeutics (DNLI) United States $1.735B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.614B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.559B 0.00
Coherus BioSciences (CHRS) United States $1.517B 0.00
REGENXBIO (RGNX) United States $1.469B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.437B 0.00
Alector (ALEC) United States $1.371B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.321B 0.00
Editas Medicine (EDIT) United States $1.237B 0.00
Sangamo Therapeutics (SGMO) United States $1.233B 0.00
RA PHARMCTL INC (RARX) United States $1.202B 0.00
Fate Therapeutics (FATE) United States $1.190B 0.00
Innoviva (INVA) United States $1.117B 3.23
AnaptysBio (ANAB) United States $1.115B 0.00
Athenex (ATNX) United States $1.100B 0.00
Zymeworks (ZYME) Canada $1.077B 0.00
Epizyme (EPZM) United States $1.007B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.993B 0.00
Twist Bioscience (TWST) United States $0.912B 0.00
Cara Therapeutics (CARA) United States $0.887B 0.00
ANI Pharmaceuticals (ANIP) United States $0.876B 14.63
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.870B 0.00
WAVE Life Sciences (WVE) Singapore $0.852B 0.00
Pharming Group (PHGUF) Netherlands $0.831B 0.00
Arvinas (ARVN) United States $0.826B 0.00
Principia Biopharma (PRNB) United States $0.815B 425.13
Zealand Pharma (ZEAL) Denmark $0.765B 8.87
Cytokineticsorporated (CYTK) United States $0.763B 0.00
Anika Therapeutics (ANIK) United States $0.732B 25.91
UROGEN PHARMA (URGN) United States $0.728B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.709B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.707B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.704B 25.40
Intellia Therapeutics (NTLA) United States $0.701B 0.00
Mesoblast (MESO) Australia $0.676B 0.00
Revance Therapeutics (RVNC) United States $0.634B 0.00
MiMedx (MDXG) United States $0.592B 0.00
DBV Technologies S.A (DBVT) France $0.571B 0.00
Heska (HSKA) United States $0.567B 73.50
Retrophin (RTRX) United States $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.532B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.526B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.522B 0.00
Cellectis S.A (CLLS) France $0.491B 0.00
Stemline Therapeutics (STML) United States $0.490B 0.00
Precision BioSciences (DTIL) United States $0.489B 0.00
Syros Pharmaceuticals (SYRS) United States $0.475B 0.00
Intra-Cellular Therapies (ITCI) United States $0.471B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.455B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.444B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Puma Biotechnology (PBYI) United States $0.421B 0.00
Agenus (AGEN) United States $0.416B 0.00
Adverum Biotechnologies (ADVM) United States $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.412B 0.00
Bellus Health (BLU) Canada $0.411B 0.00
CytomX Therapeutics (CTMX) United States $0.408B 0.00
Arcus Biosciences (RCUS) United States $0.403B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.378B 0.00
Kadmon Holdings (KDMN) United States $0.364B 0.00
AC Immune SA (ACIU) Switzerland $0.364B 26.95
Protagonist Therapeutics (PTGX) United States $0.363B 0.00
Gritstone Oncology (GRTS) United States $0.346B 0.00
Theratechnologies (THERF) Canada $0.336B 0.00
Avid Bioservices (CDMO) United States $0.335B 0.00
Prothena (PRTA) Ireland $0.334B 0.00
Scholar Rock Holding (SRRK) United States $0.330B 0.00
ADMA Biologics Inc (ADMA) United States $0.316B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
Sorrento Therapeutics (SRNE) United States $0.299B 0.00
Dynavax Technologies (DVAX) United States $0.298B 0.00
Albireo Pharma (ALBO) United States $0.298B 0.00
Kindred Biosciences (KIN) United States $0.296B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.285B 0.00
Seres Therapeutics (MCRB) United States $0.280B 0.00
Cellular Biomedicine (CBMG) United States $0.276B 0.00
Geron (GERN) United States $0.269B 0.00
Clovis Oncology (CLVS) United States $0.259B 0.00
MannKind (MNKD) United States $0.250B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.250B 0.00
PDL BioPharma (PDLI) United States $0.247B 6.35
Prometic Life Sciences (PFSCF) Canada $0.246B 0.00
Senesco Technologies (ELOX) United States $0.246B 0.00
Inovio Pharmaceuticals (INO) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.243B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
EXICURE INC (XCUR) United States $0.236B 0.00
Compugen (CGEN) Israel $0.230B 0.00
Athersys (ATHX) United States $0.220B 0.00
Spero Therapeutics (SPRO) United States $0.220B 0.00
Affimed (AFMD) Germany $0.214B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.208B 0.00
Kamada (KMDA) Israel $0.208B 7.94
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Cue Biopharma (CUE) United States $0.198B 0.00
Five Prime Therapeutics (FPRX) United States $0.192B 0.00
OSMOTICA PHARM (OSMT) United States $0.191B 0.00
Alcobra (ARCT) United States $0.189B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.185B 0.00
XOMA (XOMA) United States $0.175B 0.00
Arsanis (XFOR) United States $0.174B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.168B 0.00
Acorda Therapeutics (ACOR) United States $0.168B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Dyadic (DYAI) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Novavax (NVAX) United States $0.157B 0.00
Strongbridge Biopharma (SBBP) United States $0.145B 5.96
Paratek Pharmaceuticals (PRTK) United States $0.145B 0.00
Cerecor (CERC) United States $0.145B 0.00
Northwest Biotherapeutics (NWBO) United States $0.143B 0.00
Adocia (ADOCY) France $0.140B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
NantKwest (NK) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Menlo Therapeutics (MNLO) United States $0.114B 0.00
Fortress Biotech (FBIO) United States $0.112B 0.00
Vaccinex (VCNX) United States $0.109B 0.00
Emmaus Life Sciences (EMMA) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Verastem (VSTM) United States $0.099B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Arbutus Biopharma (ABUS) Canada $0.094B 0.00
OvaScience (MLND) United States $0.092B 0.00
Trevena (TRVN) United States $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.087B 0.00
VTv Therapeutics (VTVT) United States $0.085B 0.00
Mersana Therapeutics (MRSN) United States $0.084B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Checkpoint Therapeutics (CKPT) United States $0.082B 0.00
Curis (CRIS) United States $0.081B 0.00
Selecta Biosciences (SELB) United States $0.081B 0.00
Idera Pharmaceuticals (IDRA) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Applied Genetic Technologies (AGTC) United States $0.062B 34.20
AquaBounty Technologies (AQB) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Unum Therapeutics (UMRX) United States $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Stellar Biotechnologies (EDSA) Canada $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00
VBI Vaccines (VBIV) United States $0.049B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Ophthotech (ISEE) United States $0.047B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
BIOCARDIA INC (BCDA) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Clearside Biomedical (CLSD) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
TOCAGEN INC (TOCA) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Bionano Genomics (BNGO) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00